메뉴 건너뛰기




Volumn 45, Issue 7, 2015, Pages 637-641

Association between axillary lymph node status and Ki67 labeling index in triple-negative medullary breast carcinoma

Author keywords

Axillary lymph node metastasis; Ki67; Medullary breast carcinoma; Triple negative breast carcinoma

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

EID: 84941356117     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyv052     Document Type: Article
Times cited : (5)

References (26)
  • 1
    • 0017762831 scopus 로고
    • Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up
    • Ridolfi RL, Rosen PP, Port A, Kinne D, Miké V. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 1977;40:1365-85.
    • (1977) Cancer , vol.40 , pp. 1365-1385
    • Ridolfi, R.L.1    Rosen, P.P.2    Port, A.3    Kinne, D.4    Miké, V.5
  • 2
    • 0023917004 scopus 로고
    • Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma
    • Rapin V, Contesso G, Mouriesse H, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 1988;61:2503-10.
    • (1988) Cancer , vol.61 , pp. 2503-2510
    • Rapin, V.1    Contesso, G.2    Mouriesse, H.3
  • 3
    • 84871357082 scopus 로고    scopus 로고
    • Carcinomas with medullary features
    • Lakhani SR, Ellis LO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. Lyon: IARC Press
    • Jacquemier J, Reis-Filho JS, Lakhani SR, Rakha E. Carcinomas with medullary features. In: Lakhani SR, Ellis LO, Schnitt SJ, Tan PH, van de Vijver MJ, editors. WHO classification of tumors of the breast. Lyon: IARC Press 2012;46-7.
    • (2012) WHO classification of tumors of the breast , pp. 46-47
    • Jacquemier, J.1    Reis-Filho, J.S.2    Lakhani, S.R.3    Rakha, E.4
  • 4
    • 33646390671 scopus 로고    scopus 로고
    • Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers
    • Bertucci F, Finetti P, Cervera N, et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res 2006;66:4636-44.
    • (2006) Cancer Res , vol.66 , pp. 4636-4644
    • Bertucci, F.1    Finetti, P.2    Cervera, N.3
  • 5
    • 77955559694 scopus 로고    scopus 로고
    • Risk of mortality by histologic type of breast cancer in the United States
    • Li CI. Risk of mortality by histologic type of breast cancer in the United States. Horm Cancer 2010;1:156-65.
    • (2010) Horm Cancer , vol.1 , pp. 156-165
    • Li, C.I.1
  • 6
    • 21244462227 scopus 로고    scopus 로고
    • Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT)
    • Vu-Nishino H, Tavassoli FA, Ahrens WA, Haffty BG. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). Int J Radiat Oncol Biol Phys 2005;62:1040-7.
    • (2005) Int J Radiat Oncol Biol Phys , vol.62 , pp. 1040-1047
    • Vu-Nishino, H.1    Tavassoli, F.A.2    Ahrens, W.A.3    Haffty, B.G.4
  • 7
    • 84868116683 scopus 로고    scopus 로고
    • Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
    • Huober J1, Gelber S, Goldhirsch A, et al. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol 2012;23:2843-51.
    • (2012) Ann Oncol , vol.23 , pp. 2843-2851
    • Huober, J.1    Gelber, S.2    Goldhirsch, A.3
  • 8
    • 84876730988 scopus 로고    scopus 로고
    • Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified
    • Cao AY, He M, Huang L, Shao ZM, Di GH. Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified. World J Surg Oncol 2013;11:91.
    • (2013) World J Surg Oncol , vol.11 , pp. 91
    • Cao, A.Y.1    He, M.2    Huang, L.3    Shao, Z.M.4    Di, G.H.5
  • 10
    • 84892571466 scopus 로고    scopus 로고
    • Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma
    • Park I, Kim J, Kim M, et al. Comparison of the characteristics of medullary breast carcinoma and invasive ductal carcinoma. J Breast Cancer 2013;16:417-25.
    • (2013) J Breast Cancer , vol.16 , pp. 417-425
    • Park, I.1    Kim, J.2    Kim, M.3
  • 11
    • 0021048541 scopus 로고
    • The significance of lymph node involvement in patients with medullary carcinoma of the breast
    • Black CL, Morris DM, Goldman LI, McDonald JC. The significance of lymph node involvement in patients with medullary carcinoma of the breast. Surg Gynecol Obstet 1983;157:497-9.
    • (1983) Surg Gynecol Obstet , vol.157 , pp. 497-499
    • Black, C.L.1    Morris, D.M.2    Goldman, L.I.3    McDonald, J.C.4
  • 12
    • 0028784778 scopus 로고
    • Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases
    • Reinfuss M, Stelmach A, Mitus J, Rys J, Duda K. Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J Surg Oncol 1995;60:89-94.
    • (1995) J Surg Oncol , vol.60 , pp. 89-94
    • Reinfuss, M.1    Stelmach, A.2    Mitus, J.3    Rys, J.4    Duda, K.5
  • 13
    • 33847147313 scopus 로고    scopus 로고
    • American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    • Wolff AC1, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007;25:118-45.
    • (2007) J Clin Oncol , vol.25 , pp. 118-145
    • Wolff, A.C.1    Hammond, M.E.2    Schwartz, J.N.3
  • 15
    • 77953211478 scopus 로고    scopus 로고
    • Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach
    • Flucke U, Flucke MT, Hoy L, et al. Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach. Histopathology 2010;56:852-59.
    • (2010) Histopathology , vol.56 , pp. 852-859
    • Flucke, U.1    Flucke, M.T.2    Hoy, L.3
  • 16
    • 77955242875 scopus 로고    scopus 로고
    • Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size
    • Lee JH, Kim SH, Suh YJ, Shim BY, Kim HK. Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size. Cancer Res Treat 2010;42:30-6.
    • (2010) Cancer Res Treat , vol.42 , pp. 30-36
    • Lee, J.H.1    Kim, S.H.2    Suh, Y.J.3    Shim, B.Y.4    Kim, H.K.5
  • 17
    • 36549031706 scopus 로고    scopus 로고
    • Typical medullary carcinoma of the breast: a retrospective study about 33 cases
    • Khomsi F, Ben BachoucheW, Bouzaiene H, et al. Typical medullary carcinoma of the breast: a retrospective study about 33 cases. Gynecol Obstet Fertil 2007;35:1117-22.
    • (2007) Gynecol Obstet Fertil , vol.35 , pp. 1117-1122
    • Khomsi, F.1    Ben Bachouche, W.2    Bouzaiene, H.3
  • 18
    • 84896318363 scopus 로고    scopus 로고
    • A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women
    • Greer LT, Rosman M, Charles Mylander W, et al. A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: a focus on older women. Breast J 2014;20:147-53.
    • (2014) Breast J , vol.20 , pp. 147-153
    • Greer, L.T.1    Rosman, M.2    Charles Mylander, W.3
  • 19
    • 84877113211 scopus 로고    scopus 로고
    • Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice
    • Yoshihara E, Smeets A, Laenen A, et al. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice. Breast 2013;22:357-61.
    • (2013) Breast , vol.22 , pp. 357-361
    • Yoshihara, E.1    Smeets, A.2    Laenen, A.3
  • 20
    • 84864866573 scopus 로고    scopus 로고
    • Factors influencing axillary lymph node metastasis in invasive breast cancer
    • Li L, Chen LZ. Factors influencing axillary lymph node metastasis in invasive breast cancer. Asian Pac J Cancer Prev 2012;13:251-4.
    • (2012) Asian Pac J Cancer Prev , vol.13 , pp. 251-254
    • Li, L.1    Chen, L.Z.2
  • 21
    • 79952477226 scopus 로고    scopus 로고
    • Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma
    • Yenidunya S, Bayrak R, Haltas H. Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma. Diagn Pathol 2011;6:18.
    • (2011) Diagn Pathol , vol.6 , pp. 18
    • Yenidunya, S.1    Bayrak, R.2    Haltas, H.3
  • 22
    • 66949168510 scopus 로고    scopus 로고
    • The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast
    • Rakha EA, Aleskandarany M, El-Sayed ME, et al. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. Eur J Cancer 2009;45:1780-87.
    • (2009) Eur J Cancer , vol.45 , pp. 1780-1787
    • Rakha, E.A.1    Aleskandarany, M.2    El-Sayed, M.E.3
  • 23
    • 84865171628 scopus 로고    scopus 로고
    • Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review
    • Luporsi E, André F, Spyratos F, et al. Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review. Breast Cancer Res Treat 2012;132:895-915.
    • (2012) Breast Cancer Res Treat , vol.132 , pp. 895-915
    • Luporsi, E.1    André, F.2    Spyratos, F.3
  • 24
    • 48849096940 scopus 로고    scopus 로고
    • Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32, 825 patients
    • Stuart-Harris R, Caldas C, Pinder SE, Pharoah P. Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32, 825 patients. Breast 2008;17:323-34.
    • (2008) Breast , vol.17 , pp. 323-334
    • Stuart-Harris, R.1    Caldas, C.2    Pinder, S.E.3    Pharoah, P.4
  • 25
    • 0031827485 scopus 로고    scopus 로고
    • MIB-1 labelling index is an independent prognostic marker in primary breast cancer
    • Jansen RL, Hupperets PS, Arends JW, et al. MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer 1998;78:460-5.
    • (1998) Br J Cancer , vol.78 , pp. 460-465
    • Jansen, R.L.1    Hupperets, P.S.2    Arends, J.W.3
  • 26
    • 77955203082 scopus 로고    scopus 로고
    • Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer
    • Nishimura R1, Osako T, Okumura Y, Hayashi M, Toyozumi Y, Arima N. Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancer. Exp Ther Med 2010;1:747-54.
    • (2010) Exp Ther Med , vol.1 , pp. 747-754
    • Nishimura, R.1    Osako, T.2    Okumura, Y.3    Hayashi, M.4    Toyozumi, Y.5    Arima, N.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.